113 related articles for article (PubMed ID: 9380912)
1. [Should we screen for hemochromatosis? Critical analysis of the literature].
Charvet-Protat S; Yaouanq J; Fleurette F
Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
[TBL] [Abstract][Full Text] [Related]
2. [Genetic hemochromatosis: importance of population screening?].
Cartabellotta A; Montalto G
Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
[TBL] [Abstract][Full Text] [Related]
3. Screening for hemochromatosis: phenotype versus genotype.
Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
[TBL] [Abstract][Full Text] [Related]
4. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
[TBL] [Abstract][Full Text] [Related]
5. Screening and surveillance of Barrett's esophagus.
Regula J
Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
Reynolds TM
J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
[TBL] [Abstract][Full Text] [Related]
7. The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program.
van den Boom G; Rutten-van Mölken MP; Folgering H; van Weel C; van Schayck CP
Prev Med; 2000 Apr; 30(4):302-8. PubMed ID: 10731459
[TBL] [Abstract][Full Text] [Related]
8. Cost-benefit analysis of Helicobacter pylori screening.
Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.
Kourbatova EV; Akovbyan VA; Chesson HW; Lytkina IN; Dmitriev GA; Tikhonova LI; Koubanova AA; Petukhova II; Latypova MF; Aboymova OA; Lewis JS; Ryan CA; Shakarishvili A
Sex Transm Dis; 2008 May; 35(5):453-60. PubMed ID: 18434940
[TBL] [Abstract][Full Text] [Related]
10. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
11. Screening protocols for diseases in women: a review of screening principles and examination of practices.
Otto CN
Clin Lab Sci; 1999; 12(4):230-8. PubMed ID: 10558309
[TBL] [Abstract][Full Text] [Related]
12. Searching for hereditary hemochromatosis.
Laudicina RJ
Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
[TBL] [Abstract][Full Text] [Related]
13. Estimating true burden of disease detected by screening tests of varying validity.
Mishra RN; Mishra CP; Reddy DC; Gupta VM
Indian J Public Health; 2001; 45(1):14-9. PubMed ID: 11917314
[TBL] [Abstract][Full Text] [Related]
14. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
16. Screening for cancer: evaluating the evidence.
Gates TJ
Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
[TBL] [Abstract][Full Text] [Related]
17. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
Fisman DN; Spain CV; Salmon ME; Goldberg M
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
[TBL] [Abstract][Full Text] [Related]
20. Population-based screening for colorectal cancer: Australian research and implementation.
Young GP
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
